Credit Suisse reiterated coverage on Flexion Therapeutics with a new price target

5/13/21 11:49:43 AM ET

Major Pharmaceuticals

Health Care

Credit Suisse reiterated coverage of Flexion Therapeutics with a rating of Outperform and set a new price target of $14.00 from $17.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FLXN

Date	Price Target	Rating	Analyst
11/19/2021		Outperform → Market Perform	Northland Capital Markets
10/19/2021	$25.00 → $10.00	Buy → Neutral	HC Wainwright & Co.
10/12/2021	$20.00 → $12.00	Outperform → Market Perform	BMO Capital
10/12/2021		Strong Buy → Market Perform	Raymond James
10/12/2021	$14.00 → $10.00	Outperform → Neutral	Credit Suisse
8/6/2021	$8.00 → $6.00	Neutral	Goldman Sachs
8/5/2021	$20.00 → $18.00	Buy	Needham